药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ceforanide
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Technetium Tc-99m ciprofloxacin.
Ceforanide
Pracinostat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Pracinostat.
Ceforanide
Terlipressin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Terlipressin.
Ceforanide
Probucol
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Probucol.
Ceforanide
Gemifloxacin
The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Oxprenolol.
Ceforanide
Papaverine
The risk or severity of QTc prolongation can be increased when Papaverine is combined with Oxprenolol.
Ceforanide
Macimorelin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Macimorelin.
Ceforanide
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Deutetrabenazine.
Ceforanide
Glasdegib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Glasdegib.
Ceforanide
Ribociclib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Ribociclib.
Ceforanide
Eliglustat
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Eliglustat.
Ceforanide
Vemurafenib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Vemurafenib.
Ceforanide
Artemether
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Artemether.
Ceforanide
Asenapine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Asenapine.
Ceforanide
Romidepsin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Romidepsin.
Ceforanide
Vandetanib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Vandetanib.
Ceforanide
Iloperidone
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Iloperidone.
Ceforanide
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Tetrabenazine.
Ceforanide
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Zuclopenthixol.
Ceforanide
Temafloxacin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Temafloxacin.